Name | 3-Amino-2-methoxypyridine-5-boronic acid pinacol ester |
---|---|
Synonyms |
3-Pyridinamine, 2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
QC-4814 2-(methyloxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinamine 2-methoxy-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-pyridin-3-ylamine 3-Amino-2-methoxypyridine-5-boronic acid pinacol ester 5-Amino-6-methoxypyridine-3-boronic acid pinacol ester 2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-amine (5-amino-6-methoxypyridin-3-yl)boronic acid pinacol ester 2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinamine 2-Methoxy-5-(4,4,5,5-tetramethyl-[1,3,2] dioxaborolan-2-yl)-pyridin-3-ylamine |
Density | 1.1±0.1 g/cm3 |
---|---|
Boiling Point | 392.3±42.0 °C at 760 mmHg |
Melting Point | 144 °C |
Molecular Formula | C12H19BN2O3 |
Molecular Weight | 250.102 |
Flash Point | 191.1±27.9 °C |
Exact Mass | 250.148880 |
PSA | 66.60000 |
LogP | 1.55280 |
Vapour Pressure | 0.0±0.9 mmHg at 25°C |
Index of Refraction | 1.514 |
Storage condition | 2-8°C |
Hazard Codes | Xi |
---|---|
HS Code | 2934999090 |
~92% 893440-50-1 |
Literature: GLAXOSMITHKLINE LLC; BOTYANSZKI, Janos; DICKERSON, Scott Howard; LEIVERS, Martin Robert; LI, Xiaofei; MCFADYEN, Robert Blount; REDMAN, Aniko Maria; SHOTWELL, John Bradford; XUE, Jianjun Patent: WO2012/174312 A2, 2012 ; Location in patent: Page/Page column 287 ; WO 2012/174312 A2 |
~93% 893440-50-1 |
Literature: Su, Weiguo; Zhang, Weihan; Yang, Haibin Patent: US2013/190307 A1, 2013 ; Location in patent: Paragraph 0151; 0152 ; |
~95% 893440-50-1 |
Literature: VERTEX PHARMACEUTICALS INCORPORATED Patent: WO2006/65946 A1, 2006 ; Location in patent: Page/Page column 72 ; WO 2006/065946 A1 |
~% 893440-50-1 |
Literature: WO2012/32067 A1, ; WO 2012/032067 A1 |
~% 893440-50-1 |
Literature: WO2012/34526 A1, ; WO 2012/034526 A1 |
~% 893440-50-1 |
Literature: WO2012/32067 A1, ; WO 2012/032067 A1 |
Precursor 6 | |
---|---|
DownStream 1 | |
HS Code | 2934999090 |
---|---|
Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |